Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Theravance Biopharma - 10 Year Stock Price History | TBPH

Historical daily share price chart and data for Theravance Biopharma since 2014 adjusted for splits and dividends. The latest closing stock price for Theravance Biopharma as of April 22, 2024 is 9.46.
  • The all-time high Theravance Biopharma stock closing price was 42.56 on June 22, 2017.
  • The Theravance Biopharma 52-week high stock price is 11.98, which is 26.6% above the current share price.
  • The Theravance Biopharma 52-week low stock price is 8.21, which is 13.2% below the current share price.
  • The average Theravance Biopharma stock price for the last 52 weeks is 9.88.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Theravance Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 9.2889 11.5900 11.5900 8.2200 9.4600 -15.84%
2023 10.3301 10.9700 11.9200 8.3800 11.2400 0.18%
2022 9.7236 12.2800 12.9600 8.3300 11.2200 1.54%
2021 14.3495 17.5300 22.4600 6.7700 11.0500 -37.82%
2020 21.8099 24.6700 31.2100 14.7850 17.7700 -31.36%
2019 21.2692 26.1800 28.1500 15.6000 25.8900 1.17%
2018 26.3454 28.0700 35.0700 22.0600 25.5900 -8.25%
2017 33.1766 32.5000 42.5600 23.8800 27.8900 -12.52%
2016 24.2707 16.2400 38.5800 13.3500 31.8800 94.51%
2015 15.5786 14.7000 21.7300 10.8800 16.3900 9.85%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.454B $0.057B
Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.?
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.003B 27.54
Chugai Pharmaceutical (CHGCY) Japan $52.278B 22.70
Takeda Pharmaceutical (TAK) Japan $41.902B 6.79
Merck (MKGAF) Germany $20.162B 19.02
Astellas Pharma (ALPMY) Japan $17.192B 24.36
Shionogi (SGIOY) Japan $14.152B 12.24
Sandoz Group AG (SDZNY) Switzerland $13.930B 0.00
Neurocrine Biosciences (NBIX) United States $13.135B 54.54
United Therapeutics (UTHR) United States $11.197B 11.99
Catalent (CTLT) United States $10.040B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.926B 7.02
Ionis Pharmaceuticals (IONS) United States $5.929B 0.00
Revolution Medicines (RVMD) United States $5.751B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.231B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.219B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.991B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.767B 0.00
Indivior (INDV) United States $2.554B 11.87
Evotec AG (EVO) Germany $2.505B 0.00
Summit Therapeutics (SMMT) United States $2.456B 0.00
Corcept Therapeutics (CORT) United States $2.389B 24.16
Dyne Therapeutics (DYN) United States $2.056B 0.00
PTC Therapeutics (PTCT) United States $1.940B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.804B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.786B 18.45
NewAmsterdam Pharma (NAMS) Netherlands $1.779B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.725B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.664B 9.85
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.80
Avadel Pharmaceuticals (AVDL) Ireland $1.570B 0.00
Ardelyx (ARDX) United States $1.508B 0.00
4D Molecular Therapeutics (FDMT) United States $1.292B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.240B 11.65
Pacira BioSciences (PCRX) United States $1.221B 12.15
Soleno Therapeutics (SLNO) United States $1.217B 0.00
Collegium Pharmaceutical (COLL) United States $1.139B 7.01
Xencor (XNCR) United States $1.123B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.060B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.913B 0.00
Cronos Group (CRON) Canada $0.905B 0.00
Cassava Sciences (SAVA) United States $0.849B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.37
ARS Pharmaceuticals (SPRY) United States $0.817B 0.00
Enliven Therapeutics (ELVN) United States $0.809B 0.00
Sage Therapeutics (SAGE) United States $0.801B 0.00
Relay Therapeutics (RLAY) United States $0.782B 0.00
Ocular Therapeutix (OCUL) United States $0.776B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.722B 0.00
Silence Therapeutics (SLN) United Kingdom $0.678B 0.00
Savara (SVRA) United States $0.664B 0.00
Siga Technologies (SIGA) United States $0.593B 8.78
Lyell Immunopharma (LYEL) United States $0.567B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.557B 0.00
Verve Therapeutics (VERV) United States $0.555B 0.00
OmniAb (OABI) United States $0.547B 0.00
Korro Bio (KRRO) United States $0.535B 0.00
Exscientia (EXAI) United Kingdom $0.513B 0.00
Altimmune (ALT) United States $0.490B 0.00
KalVista Pharmaceuticals (KALV) United States $0.488B 0.00
ProKidney (PROK) United States $0.468B 0.00
Larimar Therapeutics (LRMR) United States $0.417B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.397B 0.00
Heron Therapeutics (HRTX) United States $0.397B 0.00
Tourmaline Bio (TRML) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.383B 72.50
Harrow (HROW) United States $0.370B 0.00
Esperion Therapeutics (ESPR) United States $0.369B 0.00
Nature's Sunshine Products (NATR) United States $0.363B 20.31
Bioventus (BVS) United States $0.355B 0.00
Fractyl Health (GUTS) United States $0.314B 0.00
Lyra Therapeutics (LYRA) United States $0.310B 0.00
Aquestive Therapeutics (AQST) United States $0.301B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.296B 0.00
Akebia Therapeutics (AKBA) United States $0.285B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.282B 0.00
ESSA Pharma (EPIX) Canada $0.280B 0.00
Black Diamond Therapeutics (BDTX) United States $0.272B 0.00
Metagenomi (MGX) United States $0.258B 0.00
Nanobiotix S.A (NBTX) France $0.255B 0.00
Adherex Technologies (FENC) United States $0.253B 0.00
Xeris Biopharma Holdings (XERS) United States $0.244B 0.00
Pyxis Oncology (PYXS) United States $0.242B 0.00
Telomir Pharmaceuticals (TELO) United States $0.236B 0.00
Nektar Therapeutics (NKTR) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Conduit Pharmaceuticals (CDT) United States $0.227B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Avita Medical (RCEL) United States $0.222B 0.00
Acrivon Therapeutics (ACRV) United States $0.213B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Prelude Therapeutics (PRLD) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.189B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
CytoDyn (CYDY) United States $0.154B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
MediWound (MDWD) Israel $0.150B 0.00
Regulus Therapeutics (RGLS) United States $0.139B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 13.00
Karyopharm Therapeutics (KPTI) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.134B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.127B 2.67
GlycoMimetics (GLYC) United States $0.124B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Relmada Therapeutics (RLMD) United States $0.121B 0.00
Citius Pharmaceuticals (CTXR) United States $0.120B 0.00
FibroGen (FGEN) United States $0.114B 0.00
Inotiv (NOTV) United States $0.111B 0.00
Eliem Therapeutics (ELYM) United States $0.107B 0.00
OptiNose (OPTN) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.095B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.088B 0.00
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.073B 5.95
Journey Medical (DERM) United States $0.069B 0.00
Tempest Therapeutics (TPST) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.81
BioLineRx (BLRX) Israel $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Jaguar Animal Health (JAGX) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
Nutriband (NTRB) United States $0.031B 0.00
Protara Therapeutics (TARA) United States $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
DURECT (DRRX) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.67
CERo Therapeutics Holdings (CERO) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
TherapeuticsMD (TXMD) United States $0.021B 0.00
Addex Therapeutics (ADXN) Switzerland $0.021B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Aptorum Group (APM) United Kingdom $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Inhibikase Therapeutics (IKT) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.11